Sümeyye Ayhan , Omer Bayazeid , Merve Yüzbaşıoğlu Baran , Hasan S. Yusufoglu , Funda Nuray Yalçın , Ayşe Kuruüzüm-Uz
{"title":"薰衣草对神经系统的影响。stoechas","authors":"Sümeyye Ayhan , Omer Bayazeid , Merve Yüzbaşıoğlu Baran , Hasan S. Yusufoglu , Funda Nuray Yalçın , Ayşe Kuruüzüm-Uz","doi":"10.1016/j.phytol.2025.01.005","DOIUrl":null,"url":null,"abstract":"<div><div><em>Lavandula stoechas</em> L. subsp. <em>stoechas</em> has traditionally been used in folk medicine for central nervous system (CNS) disorders. In the present study, the potential neuroactive effect of the aqueous ethanol extract of the aerial parts of <em>L. stoechas</em> was investigated, and phytochemical studies were carried out to identify the compounds that may be responsible for this activity. Five compounds were isolated using various chromatographic methods, and their structures were elucidated as luteolin 7-O-<em>β</em>-D-glucopyranoside, rosmarinic acid, eriodictyol, 1-nonadecene, and ursolic acid by spectroscopic methods. Assessing the brain-derived neurotrophic factor (BDNF) level in SH-SY5Y cells was used as a biological screening tool to evaluate the activity, and the extracts, main fractions, and isolated compounds were generally found to increase BDNF levels. Among the isolated compounds, ursolic acid at a concentration of 5 μM, as well as eriodictyol and ursolic acid at a concentration of 10 μM, resulted in the highest increase in BDNF levels. In addition, the potential neuroprotective effects of the isolated compounds against H<sub>2</sub>O<sub>2</sub>-induced neuronal cell damage were investigated. The compounds were found to possess neuroprotective effects, with significant activity observed for eriodictyol at a concentration of 5 μM (<em>p</em> < 0.05) and for 1-nonadecene at concentrations of 2.5 μM (<em>p</em> < 0.001), 5 μM (<em>p</em> < 0.01), and 10 μM (<em>p</em> < 0.001). Additionally, <em>L. stoechas</em> demonstrated strong antioxidant activity, as evidenced by DPPH, SO, NO radical scavenging activity, CUPRAC, and FRAP methods. In conclusion, our results provide support for the traditional use of <em>L. stoechas</em> in CNS disorders.</div></div>","PeriodicalId":20408,"journal":{"name":"Phytochemistry Letters","volume":"65 ","pages":"Pages 145-151"},"PeriodicalIF":1.3000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The neurologic effects of Lavandula stoechas L. subsp. stoechas\",\"authors\":\"Sümeyye Ayhan , Omer Bayazeid , Merve Yüzbaşıoğlu Baran , Hasan S. Yusufoglu , Funda Nuray Yalçın , Ayşe Kuruüzüm-Uz\",\"doi\":\"10.1016/j.phytol.2025.01.005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div><em>Lavandula stoechas</em> L. subsp. <em>stoechas</em> has traditionally been used in folk medicine for central nervous system (CNS) disorders. In the present study, the potential neuroactive effect of the aqueous ethanol extract of the aerial parts of <em>L. stoechas</em> was investigated, and phytochemical studies were carried out to identify the compounds that may be responsible for this activity. Five compounds were isolated using various chromatographic methods, and their structures were elucidated as luteolin 7-O-<em>β</em>-D-glucopyranoside, rosmarinic acid, eriodictyol, 1-nonadecene, and ursolic acid by spectroscopic methods. Assessing the brain-derived neurotrophic factor (BDNF) level in SH-SY5Y cells was used as a biological screening tool to evaluate the activity, and the extracts, main fractions, and isolated compounds were generally found to increase BDNF levels. Among the isolated compounds, ursolic acid at a concentration of 5 μM, as well as eriodictyol and ursolic acid at a concentration of 10 μM, resulted in the highest increase in BDNF levels. In addition, the potential neuroprotective effects of the isolated compounds against H<sub>2</sub>O<sub>2</sub>-induced neuronal cell damage were investigated. The compounds were found to possess neuroprotective effects, with significant activity observed for eriodictyol at a concentration of 5 μM (<em>p</em> < 0.05) and for 1-nonadecene at concentrations of 2.5 μM (<em>p</em> < 0.001), 5 μM (<em>p</em> < 0.01), and 10 μM (<em>p</em> < 0.001). Additionally, <em>L. stoechas</em> demonstrated strong antioxidant activity, as evidenced by DPPH, SO, NO radical scavenging activity, CUPRAC, and FRAP methods. In conclusion, our results provide support for the traditional use of <em>L. stoechas</em> in CNS disorders.</div></div>\",\"PeriodicalId\":20408,\"journal\":{\"name\":\"Phytochemistry Letters\",\"volume\":\"65 \",\"pages\":\"Pages 145-151\"},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2025-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Phytochemistry Letters\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1874390025000047\",\"RegionNum\":4,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Phytochemistry Letters","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1874390025000047","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
The neurologic effects of Lavandula stoechas L. subsp. stoechas
Lavandula stoechas L. subsp. stoechas has traditionally been used in folk medicine for central nervous system (CNS) disorders. In the present study, the potential neuroactive effect of the aqueous ethanol extract of the aerial parts of L. stoechas was investigated, and phytochemical studies were carried out to identify the compounds that may be responsible for this activity. Five compounds were isolated using various chromatographic methods, and their structures were elucidated as luteolin 7-O-β-D-glucopyranoside, rosmarinic acid, eriodictyol, 1-nonadecene, and ursolic acid by spectroscopic methods. Assessing the brain-derived neurotrophic factor (BDNF) level in SH-SY5Y cells was used as a biological screening tool to evaluate the activity, and the extracts, main fractions, and isolated compounds were generally found to increase BDNF levels. Among the isolated compounds, ursolic acid at a concentration of 5 μM, as well as eriodictyol and ursolic acid at a concentration of 10 μM, resulted in the highest increase in BDNF levels. In addition, the potential neuroprotective effects of the isolated compounds against H2O2-induced neuronal cell damage were investigated. The compounds were found to possess neuroprotective effects, with significant activity observed for eriodictyol at a concentration of 5 μM (p < 0.05) and for 1-nonadecene at concentrations of 2.5 μM (p < 0.001), 5 μM (p < 0.01), and 10 μM (p < 0.001). Additionally, L. stoechas demonstrated strong antioxidant activity, as evidenced by DPPH, SO, NO radical scavenging activity, CUPRAC, and FRAP methods. In conclusion, our results provide support for the traditional use of L. stoechas in CNS disorders.
期刊介绍:
Phytochemistry Letters invites rapid communications on all aspects of natural product research including:
• Structural elucidation of natural products
• Analytical evaluation of herbal medicines
• Clinical efficacy, safety and pharmacovigilance of herbal medicines
• Natural product biosynthesis
• Natural product synthesis and chemical modification
• Natural product metabolism
• Chemical ecology
• Biotechnology
• Bioassay-guided isolation
• Pharmacognosy
• Pharmacology of natural products
• Metabolomics
• Ethnobotany and traditional usage
• Genetics of natural products
Manuscripts that detail the isolation of just one new compound are not substantial enough to be sent out of review and are out of scope. Furthermore, where pharmacology has been performed on one new compound to increase the amount of novel data, the pharmacology must be substantial and/or related to the medicinal use of the producing organism.